Charles W. Finn

Symphony Dynamo, Inc. manufactures biopharmaceutical drugs. It was created to advance TLR-9 based therapeutics in hepatitis B therapy and hepatitis C therapy and cancer. The company was founded in 2002 and is headquartered in Rockville, MD.

Symphony Evolution, Inc. engages in the manufacture of biopharmaceutical drugs. It develops therapeutics to treat cancer and diabetic nephropathy. The company was founded on October 19, 2006 and is headquartered in Wilmington, DE.

Symphony ViDA, Inc. develops and manufactures biopharmaceutical drugs. Its products are used to treat the multiple forms of cancer and neovascular diseases of the eye. The company was founded in October 2008 and is headquartered in Rockville, MD.

RRD International LLC develops biopharmaceutical products. The firm offers product development support to biotechnology, pharmaceutical and medical device companies. Its services include development, strategic planning, program management and research. The company was founded by Frank L. Hurley and Charles W. Finn in 2002 and is headquartered in Rockville, MD.

Part of Quintiles Transnational Corp., BRI International, Inc. is a pharmaceutical research and development company with 445 employees. The company is based in Arlington, VA. BRI International was acquired by Quintiles Transnational Corp. on November 22, 1996 for $130.63 million. The company was founded by Harold Solomon.

Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA.

Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA.

Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC.

Symphony Neuro Development Co. manufactures pharmaceuticals. It is engaged in the research, development, and commercialization of proprietary drugs that target the hospital and neurology markets. The company is headquartered in Rockville, MD.